A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples based on distinct molecular features identified by The ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the patient will experience a recurrence years after their initial diagnosis. Now, ...

Cancer diagnoses worldwide are expected to climb to 35 million annually by 2050, up from 20.6 million in 2024, the World ...

Targeted therapy uses drugs to attack specific cancer gene mutations, often in pill or intravenous (IV) form after biomarker testing identifies the target. Benefits include targeting only cancer cells ...